EMV.AX ASX
EMVision Medical Devices Ltd
1W: -10.3%
1M: -12.4%
3M: +0.7%
YTD: -13.3%
1Y: -19.2%
3Y: -4.3%
5Y: -46.8%
A$1.58 ($1.10)
+0.02 (+1.28%)
Weekly Expected Move ±5.6%
A$1
A$1
A$2
A$2
A$2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$6M
+20.3% ▲
Capital Expenditures
$124K
-146.6% ▼
5Y CAGR: -0.5%
Free Cash Flow
-$6M
+19.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$7M
+181.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$4M | -$3M | $0 | -$8M |
| Depreciation & Amort. | $243K | $342K | $0 | $0 | $417K |
| Stock-Based Comp. | $2M | $2M | $0 | $0 | $0 |
| Change in Working Capital | $197K | $2M | -$5M | $913K | -$77K |
| Other Non-Cash Items | $2M | $2M | $1M | -$9M | $2M |
| Operating Cash Flow | -$4M | $834K | -$6M | -$8M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$191K | -$187K | -$115K | -$50K | -$124K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$187K | $0 | $0 |
| Investing Cash Flow | -$191K | -$187K | -$302K | -$50K | -$124K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$175K | $3M | -$2K | -$256K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$221K | -$244K | $0 | -$139K |
| Financing Cash Flow | $1M | $3M | $15M | -$258K | $13M |
| Net Change in Cash | -$3M | $3M | $9M | -$8M | $7M |
| Cash End of Period | $7M | $10M | $19M | $10M | $17M |
| Free Cash Flow | -$4M | $647K | -$6M | -$8M | -$6M |